Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0019158 (hepatitis)
 30,205 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Little is known about vertical transmission of hepatitis E virus from infected mothers to their infants. We studied eight babies born to mothers infected with hepatitis E in third trimester. One baby was icteric at birth with elevated transaminases and four babies had anicteric hepatitis. Two babies were born with hypothermia and hypoglycaemia and died within 24 h; one had massive hepatic necrosis. Hepatitis E virus RNA was detected by PCR in cord or birth blood samples of five infants. Six infants had evidence of hepatitis E infection. We conclude that hepatitis E virus is commonly transmitted from infected mothers to their babies with significant perinatal morbidity and mortality.
 ...
PMID:Vertical transmission of hepatitis E virus. 772 1

The hepatitis E virus (HEV) is an infection agent (detected recently) responsible for an enterically transmitted non-A, non-B hepatitis [1,2]. Hepatitis E is a big problem in many developing countries, including the Central Asian areas of the former Soviet Union [2]. By cloning followed by sequence analysis of the HEV genome, three open reading frames (ORF) have been identified, among them ORF3 encoding a protein containing 123 amino acid residues, the function of this protein being unknown. Recently [3], one of the immunodominant regions of ORF3 protein was revealed between the 91st and 123rd amino acid residue. The purpose of the present study was a more precise localization of epitopes in the C-terminal portion of HEV ORF3 protein by using synthetic peptides.
 ...
PMID:[Synthesis and antigenic activity of peptides from the ORF3 protein sequence of hepatitis E virus]. 774 9

Israel is suspected to be endemic for hepatitis E virus (HEV) because of its geographic location and the large-scale immigration from endemic countries. Although no cases of local HEV infection have been diagnosed, a serological survey would provide indirect evidence for such infection. We examined sera from 1,416 healthy subjects, including 1,139 Jews from various regions of Israel and 277 Arabs, most of whom reside in the West Bank of the Jordan River. In addition, we tested 13 non-A, non-B, and non-C viral hepatitis patients. Sera were screened for antibody to hepatitis E virus (anti-HEV) by a newly developed enzyme immunoassay (EIA) and by immunoblots for both IgG and IgM anti-HEV activity. Positive samples were confirmed by neutralization. The seroprevalence found by EIA was 2.81% and 1.81% in the Jewish and Arab populations, respectively. More than a 2-fold higher prevalence in males compared to females and an increase with age were found in both populations. However, these differences were nonsignificant. The geographical distribution was even throughout the country, except for two clusters of 3 and 4 seropositive individuals possibly reflecting past foci of infection. Eight of 37 EIA-positive sera were positive for IgG, and 3 were positive for IgM by the immunoblot assay. Among hepatitis patients (9 acute and 4 chronic), one patient with chronic hepatitis was positive for both IgG and IgM. Our study provides indirect evidence that Israel is endemic for HEV.(ABSTRACT TRUNCATED AT 250 WORDS)
 ...
PMID:Serological evidence for hepatitis E virus infection in Israel. 777 54

The presence of hepatitis E virus-specific antibodies (anti-HEV) was determined in selected Australian groups. Anti-HEV was detected initially using a recombinant antigen-based enzyme immunoassay (EIA). It was found that 1 of 279 (0.4%) blood donors, 14 of 182 (7.7%) Indochinese refugees, 2 of 89 (2.2%) sera submitted for amoebic serology (generally people who had visited developing countries), 1 of 13 (7.7%) patients with non-A, non-B hepatitis, none of 7 (0%) patients with fulminant non-A, non-B hepatitis, and none of 33 (0%) control sera were repeatedly reactive by the HEV EIA. The positive sera were subjected to further testing using a supplemental immunoblot. Preliminary data suggest that while potentially large numbers of people infected with HEV are entering Australia, no compulsive evidence was found in these particular groups for endemic HEV infection in Australia. This is the first seroepidemiological survey of HEV in Australia.
 ...
PMID:Seroepidemiology of hepatitis E in selected Australian populations. 777 56

In an attempt to reproduce experimentally the fulminant hepatitis of pregnant women infected with hepatitis E virus (HEV), 4 nonpregnant and 6 pregnant rhesus monkeys in the first, second, or third trimester of pregnancy were inoculated intravenously with approximately 10(5.5) ID50 of HEV. Comparison of biochemical, histopathologic, and serologic profiles in pregnant and nonpregnant monkeys did not reveal an increase in the severity of hepatitis in the pregnant animals. Hematology and serum clinical chemistry values were in the normal range in all animals during the study. No evidence of neonatal infection with HEV was found in offspring. Two rhesus monkeys (1 pregnant, 1 nonpregnant) had naturally occurring anti-HEV antibodies prior to inoculation as detected by a standard ELISA and confirmed by a competition ELISA with hyperimmune chimpanzee serum. These animals demonstrated an anamnestic response when they were challenged with HEV.
 ...
PMID:Experimental hepatitis E in pregnant rhesus monkeys: failure to transmit hepatitis E virus (HEV) to offspring and evidence of naturally acquired antibodies to HEV. 779 39

Hepatitis E virus (HEV) infection was detected during an epidemic in North India. Virus particles present in the stool of an acutely ill patient (YAM-67) was transmitted intravenously into rhesus monkeys (M. mulata) and orally to a human volunteer. Virus-like particles (VLPs) of 32-34 nm were detected in the bile of monkeys and in the stools of the human volunteer by means of solid phase immune electron microscopy (SPIEM) with acute homologous and heterologous sera. The VLPs were confirmed to be HEV by a reverse transcription polymerase chain reaction (RT-PCR). Virus-like particles from human volunteer stools were passaged further into rhesus monkeys. A bimodal rise in aminotransferase levels were observed in the animals, and liver histopathology indicated mild to severe form of hepatitis. Further, SPIEM and RT-PCR analysis in monkey bile revealed presence of virus from 15 to 45 days post-inoculation. Rechallenge of the animals 6 months after recovery with the same viral inoculum failed to produce abnormal liver function tests indicating the presence of protective immunity during this period. The VLPs in the stool from the patient (YAM-67) with epidemic hepatitis were found to retain infectivity even after several cycles of freeze-thawing and exposure at 37 degrees C for 2 days. Moreover, these VLPs from the patient, human volunteer, and monkeys did not react with an anti-HEV chimpanzee serum from NIH, Bethesda, MD. These findings indicate that this North India isolate of HEV is an atypical strain of HEV. The present study further validates that the rhesus monkey is a suitable experimental model for HEV.
 ...
PMID:Atypical strain of hepatitis E virus (HEV) from north India. 779 81

Epidemics caused by a faecaloral transmitted hepatitis virus other than the hepatitis A virus are reported from developing countries. This type of hepatitis is called hepatitis E and is caused by a calicivirus termed hepatitis E virus. Many characteristics of this disease are similar to those of hepatitis A. The groups usually infected are older children and young adults in developing countries with poor sanitary facilities. Faecal contamination of the drinking water is assumed to be the main path of transmission. Large epidemics with thousands of icteric cases have been described. Neither hepatitis A nor hepatitis E develops into chronicity. In pregnant women there is an unexplained high case fatality rate of nearly 20%. The available diagnostic tools are based upon demonstration of nucleic acids in the virus genome extracted from faecal and blood specimens and upon immunological tests founded on synthetic peptides or antigens developed by means of gene technology. Hepatitis E is an important kind of epidemic hepatitis in the countries of the third world. Up to now the source of the virus remains unknown, but it has been possible to inoculate and cause replication of the virus in primates and even pigs. The possibility that this kind of hepatitis is a zoonosis has to be further documented.
 ...
PMID:[New knowledge about viral hepatitis]. 782 33

Our understanding of the types of hepatitis described previously as non-A, non-B hepatitis has been revolutionized by the discovery of two new viruses, hepatitis C virus (HCV) and hepatitis E virus. HCV is transmitted parenterally, and poses a potential occupational hazard to health care workers, including dental staff. No vaccine is currently available, and it is important that an assessment of infection risk is made available to clinicians.
 ...
PMID:Occupational infection with hepatitis C virus in the healthcare setting. 786 56

The relative significance of intrafamilial transmission and continued water contamination in the spread of hepatitis E is not known. To resolve this question, two surveys were conducted during a large bimodal waterborne epidemic of hepatitis E in Kanpur, India, affecting an estimated 79,000 persons: i) April 1991: covering 420 houses (60 houses each in seven municipal wards) selected using multistage sampling and random number tables, and ii) May 1992: covering the same families in five municipal wards with incidence rates exceeding 1.5% in the first survey. The number of affected cases in each family and the time of onset of disease in each case were recorded. The time interval between the first ('index') case and the subsequent ('later') case(s) in each family was calculated. The temporal relationship of the occurrence of cases was correlated with the time of control of water contamination. One hundred and eleven hepatitis cases occurred in the 343 families (with 2018 members) studied. Eighty-one of these were single or first cases in their families. Twenty-two 'later' cases occurred within 2 weeks (minimum incubation period of hepatitis E) of the 'index' cases and could not be due to intrafamilial transmission. Thus, 103 of 111 (92.8%) cases were due to primary waterborne infection. Eight 'later' cases (7.2% of 111) that occurred 2-6 weeks after the index cases could be due either to direct spread or to intrafamilial transmission. No 'later' case occurred more than 6 weeks after the 'index' cases. New cases stopped appearing 9 weeks (upper limit of incubation period of hepatitis E) after steps to check water contamination were taken.(ABSTRACT TRUNCATED AT 250 WORDS)
 ...
PMID:Hepatitis E: intrafamilial transmission versus waterborne spread. 789 Aug 84

The transmission of blood-borne viruses in the dental office is a potential hazard to patients and dental staff, particularly to oral and maxillofacial surgeons. Hepatitis B virus has been a recognized hazard for several years, and in the past oral surgeons and other dental health care staff have been infected as a result of occupational exposure. Hepatitis C virus in contrast does not appear to be a major occupational hazard to dental staff, nevertheless, infection with this virus can lead to significant morbidity and may have oral manifestations. Hepatitis D virus can be nosocomally transmitted, but vaccination against the hepatitis B virus minimizes this problem. Hepatitis E virus is not of clinical relevance to dentistry, although dental staff who are in areas of endemic infection can become infected as a result of enteric transmission. A number of other putative viral agents may also cause hepatitis, but additional data is awaited, and their significance to dental practice is unknown. This article summarizes current data on hepatitis viruses A, B, C, D, and E.
 ...
PMID:Viral hepatitis. Current concepts for dental practice. 789 4


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>